Educations
Senators Carl Levin and Orrin Hatch hosted a forum on opioid addiction and obstacles that have made it difficult for patients to have access to buprenorphine. ASAM member Dr. Corey Waller, ABAM Diplomate, spoke on behalf of ASAM about raising the 100-patient limit.
Michael M. Miller, MD, FASAM, past president of ASAM, was elected to the American Medical Association’s Council of Science and Public Health.
Next year ASAM will celebrate the 25th anniversary of the Ruth Fox Memorial Endowment Fund. Donations have supported initiatives that were fundamental to the vision of Ruth Fox and core to the ASAM mission.
This article explores how to prescribe addiction medications.
See what articles were most accessed on <em>Journal of Addiction Medicine's</em> website in 2013.
Read a review of the top cited research from <em>Journal of Addiction Medicine</em> in 2013.
Impulsivity - or the inability to inhibit responses despite their negative consequences - may partly explain why some individuals are more prone to develop addiction when exposed to drugs of abuse. For clinicians, understanding the neuroscience underlying impulsive behavior is central to improving treatment outcomes for addiction.
See this year's winning presentation on a integrated model of treatment that improves patient care.
Every chronic medical disease employs and encourages the use of medications in concert with life-style changes. Addiction medicine should examine the benefit of following suit.
ASAM's New Jersey Chapter worked with state and federal agencies to host a training event for practitioners.
Patients have an underlying need - which may undo the rest of treatment if it is not met - the need to be heard
The June issue of ASAM’s <em>Journal of Addiction Medicine</em> included a review about the use of naloxone for rapid drug reversal.<!-- Further study on naloxone’s impact on overdose deaths, the benefits of these prevention programs at the population level, and the effectiveness and implementation on opioid overdose prevention programs in existing treatment centers is recommended.-->
ASAM member Yngvild Olsen, MD, MPH offers the New England Journal of Medicine her perspective on the challenges surrounding the FDA’s contentious approval of Zohydro.
[Addiction] is not a moral issue. This is a brain illness. The American Society of Addiction Medicine calls this a brain illness - it's not a matter of bad choices or bad behavior.
Current active members (except student and associate members) will have the opportunity to vote for the slate of candidates in the late fall. The election will be electronic and accessible by an individualized code mailed to each member. Biographies of each candidate will be available soon on the ASAM website.
Applying the principles of the ASAM criteria in daily practice was the focus of the Med-Sci Pre-Conference, “The ASAM Criteria Book and Software Live Course.”
SAMHSA is proud to have ASAM as a national partner in support of SAMHSA’s third annual National Prevention Week 2014. Addressing the problems of alcohol abuse and illicit drug use requires a comprehensive strategy.
Local policy decisions around the nation are impacting the ability of ASAM members to practice medicine, with members encountering restrictions like those that limit patient ability to access prescribed medication.
ASAM members are encouraged to participate in the ASAM 2014 election this fall to choose officers and Directors-at-Large including the Society’s first Vice President.
